These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 7959286

  • 1. Comparative studies of taxol and taxotere on tumor growth and lymphocyte functions.
    Munkarah A, Chuang L, Lotzová E, Cook K, Morris M, Wharton JT.
    Gynecol Oncol; 1994 Nov; 55(2):211-6. PubMed ID: 7959286
    [Abstract] [Full Text] [Related]

  • 2. Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol.
    Chuang LT, Lotzová E, Heath J, Cook KR, Munkarah A, Morris M, Wharton JT.
    Cancer Res; 1994 Mar 01; 54(5):1286-91. PubMed ID: 7907000
    [Abstract] [Full Text] [Related]

  • 3. In vitro cytotoxic activity of Taxol and Taxotere on primary cultures and established cell lines of human ovarian cancer.
    Silvestrini R, Zaffaroni N, Orlandi L, Oriana S.
    Stem Cells; 1993 Nov 01; 11(6):528-35. PubMed ID: 7906583
    [Abstract] [Full Text] [Related]

  • 4. Effect of new investigational drug taxol on oncolytic activity and stimulation of human lymphocytes.
    Chuang LT, Lotzová E, Cook KR, Cristoforoni P, Morris M, Wharton JT.
    Gynecol Oncol; 1993 Jun 01; 49(3):291-8. PubMed ID: 8100207
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR, Abel G.
    Cancer Chemother Pharmacol; 1992 Jun 01; 30(6):444-50. PubMed ID: 1356649
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
    Hennequin C, Giocanti N, Favaudon V.
    Cancer Res; 1996 Apr 15; 56(8):1842-50. PubMed ID: 8620502
    [Abstract] [Full Text] [Related]

  • 8. Taxotere inhibits in-vitro growth of human colonic cancer cell lines.
    Karantanis E, Nicholson S, Morris DL.
    Eur J Surg Oncol; 1994 Dec 15; 20(6):653-7. PubMed ID: 7995417
    [Abstract] [Full Text] [Related]

  • 9. Taxol and taxotere in bladder cancer: in vitro activity and urine stability.
    Rangel C, Niell H, Miller A, Cox C.
    Cancer Chemother Pharmacol; 1994 Dec 15; 33(6):460-4. PubMed ID: 7907952
    [Abstract] [Full Text] [Related]

  • 10. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
    Braakhuis BJ, Hill BT, Dietel M, Kelland LR, Aapro MS, Zoli W, Lelieveld P.
    Anticancer Res; 1994 Dec 15; 14(1A):205-8. PubMed ID: 7909419
    [Abstract] [Full Text] [Related]

  • 11. [Synthesis and cytotoxicity of the new taxoids].
    Yao F, Guo J, Liang X.
    Yao Xue Xue Bao; 1998 Sep 15; 33(9):659-65. PubMed ID: 12016869
    [Abstract] [Full Text] [Related]

  • 12. Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion.
    Bissett D, Setanoians A, Cassidy J, Graham MA, Chadwick GA, Wilson P, Auzannet V, Le Bail N, Kaye SB, Kerr DJ.
    Cancer Res; 1993 Feb 01; 53(3):523-7. PubMed ID: 8093854
    [Abstract] [Full Text] [Related]

  • 13. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer.
    Lee LF, Schuerer-Maly CC, Lofquist AK, van Haaften-Day C, Ting JP, White CM, Martin BK, Haskill JS.
    Cancer Res; 1996 Mar 15; 56(6):1303-8. PubMed ID: 8640818
    [Abstract] [Full Text] [Related]

  • 14. Identification of the structural region of taxol that may be responsible for cytokine gene induction and cytotoxicity in human ovarian cancer cells.
    Watson JM, Kingston DG, Chordia MD, Chaudhary AG, Rinehart CA, Haskill JS.
    Cancer Chemother Pharmacol; 1998 Mar 15; 41(5):391-7. PubMed ID: 9523735
    [Abstract] [Full Text] [Related]

  • 15. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
    Rosenblum MD, Shivers RR.
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan 15; 125(1):121-31. PubMed ID: 11790336
    [Abstract] [Full Text] [Related]

  • 16. The scientific rationale for developing taxoids.
    Aapro M.
    Anticancer Drugs; 1996 Aug 15; 7 Suppl 2():33-6. PubMed ID: 8862709
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol.
    Yu D, Liu B, Jing T, Sun D, Price JE, Singletary SE, Ibrahim N, Hortobagyi GN, Hung MC.
    Oncogene; 1998 Apr 23; 16(16):2087-94. PubMed ID: 9572489
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer.
    Boven E, Venema-Gaberscek E, Erkelens CA, Bissery MC, Pinedo HM.
    Ann Oncol; 1993 Apr 23; 4(4):321-4. PubMed ID: 8100146
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.